NASDAQ:CYPH Cypherpunk Technologies (CYPH) Stock Price, News & Analysis $2.42 0.00 (0.00%) As of 09/4/2026 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Cypherpunk Technologies Stock (NASDAQ:CYPH) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get CYPH alerts:Sign Up Key Stats Today's Range$2.13▼$2.4950-Day Range$0.59▼$2.4252-Week Range$0.27▼$3.70Volume16.90 million shsAverage Volume9.25 million shsMarket Capitalization$260.78 millionP/E Ratio4.32Dividend YieldN/APrice Target$1.60Consensus RatingHold Company Overview Cypherpunk Technologies Inc., previously known as Leap Therapeutics, Inc., is a company developing novel therapies for patients with cancer and implementing a digital asset treasury strategy focused on Zcash. The company’s research platform centers on modulating the tumor microenvironment to enhance anti-tumor immune responses. Cypherpunk’s proprietary pipeline includes DKN-01, a monoclonal antibody designed to neutralize Dickkopf-1 (DKK1), a protein implicated in tumor growth and immune evasion. DKN-01 is being evaluated both as a monotherapy and in combination with checkpoint inhibitors such as pembrolizumab across multiple solid tumor indications, including gastroesophageal, pancreatic and other advanced malignancies. In addition to DKN-01, Cypherpunk is advancing preclinical programs that target novel pathways involved in cancer cell signaling and immune regulation, with the aim of identifying complementary assets for future clinical development. Founded in 2016 and headquartered in Irvine, California, Leap Therapeutics completed its initial public offering in 2019 and now trades on the NASDAQ under the ticker CYPH. The company conducts clinical trials in the United States and collaborates with academic and industry partners to accelerate its development programs. Michael Stoll, M.D., serves as President and Chief Executive Officer, overseeing a team of experienced professionals in oncology drug discovery and development. AI Generated. May Contain Errors. Read More Cypherpunk Technologies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks32nd Percentile Overall ScoreCYPH MarketRank™: Cypherpunk Technologies scored higher than 32% of companies evaluated by MarketBeat, and ranked 734th out of 906 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.4 / 5Analyst RatingHold Consensus RatingCypherpunk Technologies has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 1 sell rating.Downside RiskCypherpunk Technologies has a consensus price target of $1.60, representing about 33.9% downside from its current price of $2.42.Amount of Analyst CoverageCypherpunk Technologies has only been the subject of 2 research reports in the past 90 days.Read more about Cypherpunk Technologies' stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Cypherpunk Technologies is 4.32, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.26.Price to Earnings Ratio vs. SectorThe P/E ratio of Cypherpunk Technologies is 4.32, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 273.26.Price to Book Value per Share RatioCypherpunk Technologies has a P/B Ratio of 1.32. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted6.47% of the float of Cypherpunk Technologies has been sold short.Short Interest Ratio / Days to CoverCypherpunk Technologies has a short interest ratio ("days to cover") of 5.22.Change versus previous monthShort interest in Cypherpunk Technologies has recently decreased by 7.75%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCypherpunk Technologies does not currently pay a dividend.Dividend GrowthCypherpunk Technologies does not have a long track record of dividend growth. News and Social Media3.7 / 5News Sentiment1.00 News SentimentCypherpunk Technologies has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.79 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Cypherpunk Technologies this week, compared to 2 articles on an average week.Search Interest5 people have searched for CYPH on MarketBeat in the last 30 days. This is an increase of 400% compared to the previous 30 days.MarketBeat Follows2 people have added Cypherpunk Technologies to their MarketBeat watchlist in the last 30 days. Company Ownership1.2 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Cypherpunk Technologies insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $34,400.00 in company stock.Percentage Held by Insiders3.50% of the stock of Cypherpunk Technologies is held by insiders.Percentage Held by Institutions30.46% of the stock of Cypherpunk Technologies is held by institutions.Read more about Cypherpunk Technologies' insider trading history. Receive CYPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cypherpunk Technologies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CYPH Stock News HeadlinesCypherpunk Technologies (NASDAQ:CYPH) Earns Overweight Rating from Cantor FitzgeraldAugust 29, 2026 | americanbankingnews.comCypherpunk Technologies (NASDAQ:CYPH) Director Sells 20,000 Shares of StockAugust 28, 2026 | insidertrades.comThis sub-5 dollar stock operates next to SpaceX and Blue OriginA small public company trading under $5 a share operates inside the secure perimeter of Kennedy Space Center, right alongside SpaceX and Blue Origin. It holds a special agreement to use a multi-billion dollar federal launch facility for just $500, and its customer list already includes the Pentagon, Lockheed Martin, and GE Aerospace. Most Wall Street analysts have not caught on yet, but a major milestone could change that soon.September 8 at 1:00 AM | Freedom Financial (Ad)Insider Shake-Up at Cypherpunk Technologies Sparks Investor BuzzAugust 27, 2026 | tipranks.comCrypto Biz: Treasury’s ‘Not-QE’ playbook sends Bitcoin higherAugust 21, 2026 | cointelegraph.comWinklevoss-Backed Cypherpunk Seizes 18% of Total Zcash HashrateAugust 18, 2026 | news.bitcoin.comCypherpunk Technologies Launches World's Largest Zcash Mining FleetAugust 18, 2026 | prnewswire.comCypherpunk Technologies Inc.: Cypherpunk Technologies Reports Second Quarter 2026 Financial ResultsAugust 12, 2026 | finanznachrichten.deSee More Headlines CYPH Stock Analysis - Frequently Asked Questions How have CYPH shares performed this year? Cypherpunk Technologies' stock was trading at $1.16 at the beginning of the year. Since then, CYPH stock has increased by 108.6% and is now trading at $2.42. How were Cypherpunk Technologies' earnings last quarter? Cypherpunk Technologies (NASDAQ:CYPH) announced its earnings results on Wednesday, August, 12th. The company reported $0.18 earnings per share (EPS) for the quarter. When did Cypherpunk Technologies' stock split? Cypherpunk Technologies's stock reverse split before market open on Wednesday, June 21st 2023.The 1-10 reverse split was announced on Wednesday, June 21st 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, June 21st 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. Who are Cypherpunk Technologies' major shareholders? Cypherpunk Technologies' top institutional investors include Cygnus Capital Advisors LLC (0.23%). View institutional ownership trends. How do I buy shares of Cypherpunk Technologies? Shares of CYPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/12/2026Today9/08/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (2w+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 For the last 2 weeks, CYPH's financial health has been in the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolNASDAQ:CYPH Previous SymbolNASDAQ:LPTX CIK1509745 Webwww.leaptx.com Phone(617) 714-0360FaxN/AEmployees40Year Founded2011Price Target and Rating Average Price Target for Cypherpunk Technologies$1.60 High Price Target$1.60 Low Price Target$1.60 Potential Upside/Downside-33.9%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)$0.56 Trailing P/E Ratio4.32 Forward P/E RatioN/A P/E GrowthN/ANet Income$4.82 million Net MarginsN/A Pretax MarginN/A Return on Equity-20.76% Return on Assets-19.48% Debt Debt-to-Equity RatioN/A Current Ratio79.19 Quick Ratio79.19 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$1.83 per share Price / Book1.32Miscellaneous Outstanding Shares107,760,000Free Float103,992,000Market Cap$260.78 million OptionableOptionable Beta0.33 Social Links 7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NASDAQ:CYPH) was last updated on 9/8/2026 by MarketBeat.com Staff. From Our PartnersA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredThe trade I’ve been waiting for since 2011Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...Traders Agency | SponsoredWhy the Treasury still prices gold at 42 dollars an ounceThe U.S. Treasury still values its gold reserves at 42.22 dollars an ounce, a price set in 1973. Gold trades n...Golden Portfolio | SponsoredThey're not buying gold. They're buying this.Bank of America raised its stake in a small gold company by 139%. Jane Street increased its position by 159%, ...Behind the Markets | SponsoredWhat Is A Roth Conversion, And How Do I Set One Up?A Roth conversion moves money from a traditional IRA or employer plan into a Roth IRA, triggering income tax t...SmartAsset | SponsoredBuffett’s “Green New Deal” (trigger warning!)Warren Buffett's largest stock bet ever now tops 29 billion dollars, dwarfing his historic positions in Coca-C...Porter & Company | SponsoredI found Rolls-Royce at $2 - now I see the same setup againIn 2022, Karim Rahemtulla recommended Rolls-Royce under $2 - a misunderstood aerospace name the market had wri...Monument Traders Alliance | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cypherpunk Technologies Please log in to your account or sign up in order to add this asset to your watchlist. Share Cypherpunk Technologies With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CYPH Stock Alerts